Chronic infections and atherosclerosis.

Area of Science:

• Cardiovascular Medicine
• Infectious Diseases
• Pathology

Background:

• Established risk factors for atherosclerosis do not fully explain coronary heart disease (CHD) epidemiology.
• Infectious agents are increasingly recognized as potential contributors to CHD development.
• Chronic infections may link inflammation and atherogenesis, influencing disease presentation.

Purpose of the Study:

• To investigate the role of infectious diseases as a risk factor for coronary heart disease (CHD).
• To explore the association between specific microorganisms (Chlamydia pneumoniae, Cytomegalovirus, Helicobacter pylori) and CHD.
• To understand how chronic infections contribute to the inflammatory processes in atherogenesis.

Main Methods:

• Review of epidemiological studies, pathology of atherosclerotic plaques, animal models, and molecular biology.
• Analysis of results from clinical antibiotic trials.
• Examination of the impact of chronic infection on T cell activation and plaque stability.

Main Results:

• Epidemiological, pathological, and molecular data suggest a positive association between Chlamydia pneumoniae infection and CHD.
• Chronic infections may destabilize atherosclerotic plaques by enhancing T cell activation.
• The precise pathophysiological mechanisms linking infections and CHD require further elucidation.

Conclusions:

• Chronic infections, particularly with Chlamydia pneumoniae, may play a significant role in the etiology of CHD.
• Inflammation driven by chronic infections is a key factor in atherogenesis.
• Future antibiotic intervention studies are crucial to confirm the role of infection and inflammation in CHD.